Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: March 12, 2009
Last updated: January 23, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)